Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 13/20 | 0.40 |
| ▸ | NPC1 | O15118 | 12/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 11/20 | 0.40 |
| ▸ | PKM | P14618 | 5/20 | 0.40 |
| ▸ | GFER | P55789 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | MIF | P14174 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 7/20 | 0.40 |
| ▸ | POLB | P06746 | 3/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 3/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8735364 | 0.97 | RAB9A (0.42) | RAB9ANPC1KDM4EPKMGFER | |
| SCHEMBL15930325 | 0.86 | RAB9A (0.42) | RAB9ANPC1KDM4EPKMGFER | |
| SCHEMBL15930321 | 0.86 | RAB9A (0.42) | RAB9ANPC1KDM4EPKMGFER | |
| SCHEMBL12865721 | 0.84 | KDM4E (0.38) | KDM4E | |
| SCHEMBL15930427 | 0.84 | KDM4E (0.42) | RAB9ANPC1KDM4EPKMGFER | |
| SCHEMBL15930437 | 0.84 | KDM4E (0.42) | RAB9ANPC1KDM4EPKMGFER | |
| SCHEMBL8735610 | 0.84 | PDK2 (0.33) | KDM4ESMN1; SMN2 | |
| SCHEMBL9888856 | 0.83 | RAB9A (0.49) | RAB9ANPC1KDM4EPKMGFER | |
| SCHEMBL17692346 | 0.82 | KDM4E (0.38) | KDM4E | |
| SCHEMBL8735655 | 0.81 | PDK2 (0.33) | KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9266851-B2 | Fluorene-containing aromatic compound, material for organic electroluminescent element, and organic electroluminescent element using same | IDEMITSU KOSAN CO., LTD. (JP) | 2016-02-23 | — | — | US | disclosed |
| US-9266851-B2 | Fluorene-containing aromatic compound, material for organic electroluminescent element, and organic electroluminescent element using same | IDEMITSU KOSAN CO., LTD. (JP) | 2016-02-23 | — | — | US | disclosed |
| US-20120126217-A1 | FLUORENE-CONTAINING AROMATIC COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | IDEMITSU KOSAN CO. LTD. (JP) | 2012-05-24 | — | — | US | disclosed |
| US-20120126217-A1 | FLUORENE-CONTAINING AROMATIC COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | IDEMITSU KOSAN CO. LTD. (JP) | 2012-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120126217-A1 | FLUORENE-CONTAINING AROMATIC COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | NR0B2, AFF2, AFF1 | RAB9A 3830/4885NPC1 556/4885KDM4E 2744/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.